Cargando…

Bioenergetic Dysfunction and Inflammation in Alzheimer’s Disease: A Possible Connection

Inflammation is observed in Alzheimer’s disease (AD) subject brains. Inflammation-relevant genes are increasingly implicated in AD genetic studies, and inflammatory cytokines to some extent even function as peripheral biomarkers. What underlies AD inflammation is unclear, but no “foreign” agent has...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wilkins, Heather M., Carl, Steven M., Greenlief, Alison C. S., Festoff, Barry W., Swerdlow, Russell H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226164/ https://www.ncbi.nlm.nih.gov/pubmed/25426068 http://dx.doi.org/10.3389/fnagi.2014.00311

Ejemplares similares

Neuronal Mitochondrial Dysfunction and Bioenergetic Failure in Inflammation-Associated Depression
por: Casaril, Angela Maria, et al.
Publicado: (2021)

Bioenergetic and inflammatory systemic phenotypes in Alzheimer’s disease APOE ε4‐carriers
por: Wilkins, Heather M., et al.
Publicado: (2021)

Insulin Resistance and Alzheimer’s Disease: Bioenergetic Linkages
por: Neth, Bryan J., et al.
Publicado: (2017)

Mitochondrial links between brain aging and Alzheimer’s disease
por: Wilkins, Heather M., et al.
Publicado: (2021)

Perimenopause and emergence of an Alzheimer’s bioenergetic phenotype in brain and periphery
por: Mosconi, Lisa, et al.
Publicado: (2017)

The Role of Bioenergetics in Neurodegeneration
por: Strope, Taylor A., et al.
Publicado: (2022)

Mitochondrial Bioenergetics Is Altered in Fibroblasts from Patients with Sporadic Alzheimer's Disease
por: Pérez, María J., et al.
Publicado: (2017)

HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer’s disease
por: Festoff, Barry W., et al.
Publicado: (2016)

Dysfunctional Mitochondrial Bioenergetics and Synaptic Degeneration in Alzheimer Disease
por: Tang, Jason, et al.
Publicado: (2019)

ATP Synthase and Mitochondrial Bioenergetics Dysfunction in Alzheimer’s Disease
por: Patro, Somya, et al.
Publicado: (2021)

Mitochondrial Dysfunction in Alzheimer’s Disease and the Rationale for Bioenergetics Based Therapies
por: Onyango, Isaac G., et al.
Publicado: (2016)

Correction: Perimenopause and emergence of an Alzheimer's bioenergetic phenotype in brain and periphery
por: Mosconi, Lisa, et al.
Publicado: (2018)

Cytoplasmic hybrid (cybrid) cell lines as a practical model for mitochondriopathies
por: Wilkins, Heather M., et al.
Publicado: (2014)

Characterization of the Meal-Stimulated Incretin Response and Relationship With Structural Brain Outcomes in Aging and Alzheimer’s Disease
por: Morris, Jill K., et al.
Publicado: (2020)

Plasma glycocholic acid and linoleic acid identified as potential mediators of mitochondrial bioenergetics in Alzheimer’s dementia
por: Amick, K. Allison, et al.
Publicado: (2022)

Mitochondrial Dysfunction and Stress Responses in Alzheimer’s Disease
por: Weidling, Ian, et al.
Publicado: (2019)

Editorial: Metabolism in Alzheimer's Disease
por: Morris, Jill K., et al.
Publicado: (2022)

Proximate Mediators of Microvascular Dysfunction at the Blood-Brain Barrier: Neuroinflammatory Pathways to Neurodegeneration
por: Festoff, Barry W., et al.
Publicado: (2017)

Cell type and sex specific mitochondrial phenotypes in iPSC derived models of Alzheimer’s disease
por: Flannagan, Kaitlin, et al.
Publicado: (2023)

Bioenergetics and Autophagic Imbalance in Patients-Derived Cell Models of Parkinson Disease Supports Systemic Dysfunction in Neurodegeneration
por: González-Casacuberta, Ingrid, et al.
Publicado: (2019)

Potential for Ketotherapies as Amyloid-Regulating Treatment in Individuals at Risk for Alzheimer’s Disease
por: Taylor, Matthew K., et al.
Publicado: (2022)

Tackling Dysfunction of Mitochondrial Bioenergetics in the Brain
por: Zanfardino, Paola, et al.
Publicado: (2021)

Alzheimer’s disease and multiple sclerosis: a possible connection through the viral demyelinating neurodegenerative trigger (vDENT)
por: Boukhvalova, Marina S., et al.
Publicado: (2023)

Bioenergetic Mechanisms of Seizure Control
por: Kovács, Richard, et al.
Publicado: (2018)

The Causal Role of Lipoxidative Damage in Mitochondrial Bioenergetic Dysfunction Linked to Alzheimer’s Disease Pathology
por: Jové, Mariona, et al.
Publicado: (2021)

Editorial: Systemic implications of Alzheimer's disease
por: Cortes, Constanza J., et al.
Publicado: (2023)

Investigations Into Bioenergetic Neuroprotection of Cone Photoreceptors: Relevance to Retinitis Pigmentosa
por: Narayan, Daniel S., et al.
Publicado: (2019)

Bioenergetic failure, mitochondrial dysfunction and mitophagy
por: Beart, Philip
Publicado: (2015)

Evaluation of Bioenergetic Function in Cerebral Vascular Endothelial Cells
por: Rellick, Stephanie L., et al.
Publicado: (2016)

Bioenergetics and Abnormal Functional Connectivity in Psychotic Disorders
por: Song, Xiaopeng, et al.
Publicado: (2021)

Effective Connectivity Modeling for fMRI: Six Issues and Possible Solutions Using Linear Dynamic Systems
por: Smith, Jason F., et al.
Publicado: (2012)

Is Drp1 a link between mitochondrial dysfunction and inflammation in Alzheimer’s disease?
por: Sbai, Oualid, et al.
Publicado: (2023)

Cerebellar Dysfunction in Multiple Sclerosis
por: Wilkins, Alastair
Publicado: (2017)

Neuronal Culture Microenvironments Determine Preferences in Bioenergetic Pathway Use
por: Sünwoldt, Juliane, et al.
Publicado: (2017)

Mitochondrial Dynamics and Bioenergetic Alteration During Inflammatory Activation of Astrocytes
por: Rahman, Md Habibur, et al.
Publicado: (2020)

NPTX2 and cognitive dysfunction in Alzheimer’s Disease
por: Xiao, Mei-Fang, et al.
Publicado: (2017)

Platelet cytochrome oxidase and citrate synthase activities in APOE ε4 carrier and non-carrier Alzheimer's disease patients
por: Wilkins, Heather M., et al.
Publicado: (2017)

Structural Connectivity in Down Syndrome and Alzheimer’s Disease
por: Saini, Fedal, et al.
Publicado: (2022)

Application of Metabolomics in Alzheimer’s Disease
por: Wilkins, Jordan Maximillian, et al.
Publicado: (2018)

Tau Clearance Mechanisms and Their Possible Role in the Pathogenesis of Alzheimer Disease
por: Chesser, Adrianne S., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_1tgfeijp9i38arlrhsv5lo1d7i